Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009)

Pharmacopsychiatry

Volumn 45, Issue 1, 2012, Pages 7-12

  Xiang, Y T ^a,b   Wang, C Y ^b   Si, T M ^c   Lee, E H M ^a   He, Y L ^d   Ungvari, G S ^e   Chiu, H F K ^a   Yang, S Y ^f   Chong, M Y ^g   Tan, C H ^h   Kua, E H ^h   Fujii, S ⁱ   Sim, K ^j   Yong, K H ^j   Trivedi, J K ^k   Chung, E K ^l   Udomratn, P ^m   Chee, K Y ⁿ   Sartorius, N ^o   Shinfuku, N ^p  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^d SHANGHAI MENTAL HEALTH CENTER   (China)

^e UNIVERSITY OF NOTRE DAME   (Australia)

^f TAIPEI CITY HOSPITAL   (Taiwan)

^g CHANG GUNG UNIVERSITY   (Taiwan)

^h NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

ⁱ Hyogo Institute for Traumatic Stress HITS   (Japan)

^j INSTITUTE OF MENTAL HEALTH   (Singapore)

^k KING GEORGE'S MEDICAL UNIVERSITY   (India)

^l Seoul National University   (South Korea)

^m PRINCE OF SONGKLA UNIVERSITY   (Thailand)

ⁿ HOSPITAL KUALA LUMPUR   (Malaysia)

^o Association for the Improvement of Mental Health Programs   (Switzerland)

^p SEINAN GAKUIN UNIVERSITY   (Japan)

more..

Author keywords

antipsychotic polypharmacy; prescription patterns; schizophrenia

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; OLANZAPINE; PEROSPIRONE; QUETIAPINE; RISPERIDONE; SULPIRIDE; ZIPRASIDONE; ZOTEPINE;

ADULT; ASIA; CLINICAL PROTOCOL; CONTROLLED STUDY; DATA COLLECTION METHOD; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

ADULT; AGE FACTORS; AGED; ANTIPSYCHOTIC AGENTS; ASIA; COHORT STUDIES; DELAYED-ACTION PREPARATIONS; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; FEMALE; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84855345384     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0031-1286345     Document Type: Review

References (29)

1. Pickar D, Vinik J, Bartko J J. Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use. PLoS ONE: 2008; 3 e3150
2. Remington G, Saha A, Chong S A et al. Augmentation strategies in clozapine-resistant schizophrenia. CNS Drugs: 2005; 19 843 872 (Pubitemid 43140687)
3. Mojtabai R, Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry: 2010; 67 26 36
4. Nunley M. Why psychiatrists in India prescribe so many drugs. Cult Med Psychiatry: 1996; 20 165 197 (Pubitemid 126706548)
5. Phillips M R, Lu S H, Wang R W. Economic reforms and the acute inpatient care of patients with schizophrenia: the Chinese experience. Am J Psychiatry: 1997; 154 1228 1234 (Pubitemid 27369173)
6. Freudenreich O, Goff D C. Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Acta Psychiatr Scand: 2002; 106 323 330 (Pubitemid 35176874)
7. Honer W G, Thornton A E, Chen E Y et al. Clozapine alone versus clozapine and risperidone with refractory schizophrenia. N. Engl J Med: 2006; 354 472 482 (Pubitemid 43200298)
8. Zink M, Englisch S, Meyer-Lindenberg A. Polypharmacy in schizophrenia. Curr. Opin Psychiatry: 2010; 23 103 111
9. Sim K, Su A, Fujii S et al. Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia. Br J Clin Pharmacol: 2004; 58 178 183 (Pubitemid 39043998)
10. Chong M Y, Tan C H, Fujii S et al. Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change. Psychiatry Clin Neurosci: 2004; 58 61 67 (Pubitemid 38200373)
11. Percudani M, Barbui C, Fortino I et al. Epidemiology of first- and second-generation antipsychotic agents in Lombardy, Italy. Pharmacopsychiatry: 2005; 38 128 131 (Pubitemid 40965966)
12. APA Practice Guideline for the Treatment of Patients with Schizophrenia. Washington, DC American Psychiatric Press: 1997
13. Kane J M, Aguglia E, Altamura A C et al. Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy. Eur Neuropsychopharmacol: 1998; 8 55 66
14. Woods S W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry: 2003; 64 663 667 (Pubitemid 36750143)
15. Ito C, Kubota Y, Sato M. A prospective survey on drug choice for prescriptions for admitted patients with schizophrenia. Psychiatry Clin Neurosci: 1999; 53 Suppl S35 S40
16. Xiang Y T, Weng Y Z, Leung C M et al. Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia. Pharmacopsychiatry: 2007; 40 47 52
17. Covell N H, Jackson C T, Evans A C et al. Antipsychotic prescribing practices in Connecticuts public mental health system: rates of changing medications and prescribing styles. Schizophr Bull: 2002; 28 17 29 (Pubitemid 34534747)
18. Weissman E M. Antipsychotic prescribing practices in the Veterans Healthcare Administration New York metropolitan region. Schizophr Bull: 2002; 28 31 42 (Pubitemid 34534748)
19. Chong S A, Sachdev P, Mahendran R et al. Neuroleptic and anticholinergic drug use in Chinese patients with schizophrenia resident in a state psychiatric hospital in Singapore. Aust N Z J Psychiatry: 2000; 34 988 991
20. Chinese Medical Association Guideline for the Prevention and Treatment of Schizophrenia in China. Beijing Chinese Medical Association: 2003
21. Lehman A F, Lieberman J A, Dixon L B et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry: 2004; 161 1 56
22. Miller A L, Hall C S, Buchanan R W et al. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry: 2004; 65 500 508
23. Suppes T, Dennehy E B, Hirschfeld R M et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry: 2005; 66 870 886 (Pubitemid 41032829)
24. Sim K, Su A, Chan Y H et al. Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore. Psychiatry Clin Neurosci: 2004; 58 324 329 (Pubitemid 38859016)
25. Binder R L, Kazamatsuri H, Nishimura T et al. Tardive dyskinesia and neuroleptic-induced parkinsonism in Japan. Am J Psychiatry: 1987; 144 1494 1496 (Pubitemid 18009548)
26. Stahl S M. Antipsychotic polypharmacy: squandering precious resources? J Clin Psychiatry: 2002; 63 93 94 (Pubitemid 34173843)
27. Barbui C, Signoretti A, Mule S et al. Does the addition of a second antipsychotic drug improve clozapine treatment? Schizophr Bull: 2009; 35 458 468
28. Cipriani A, Boso M, Barbui C. Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. Cochrane Database Syst Rev: 2009; CD006324
29. Taylor D, Paton C, Kerwin R. The Maudsley Prescribing Guidelines. London Martin Dunitz: 2003